Skip to main content
Fig. 6 | Basic and Clinical Andrology

Fig. 6

From: Improvement of erectile dysfunction using endothelial progenitor cells from fetal cerebral vasculature in the cavernous nerve injury of rats

Fig. 6

Expression of cavernous smooth muscle and endothelial makers. Expression of cavernous smooth muscle and endothelial makers after transplantation of HEN6. A-D Sham operation group, E–H Cavernous nerve injury group, I-L HEN6 transplantation group at 2 weeks after transplantation. M-P HEN6 transplantation group at 4 weeks after transplantation. Q-T HEN6 transplantation group at 12 weeks after transplantation. The group with cavernous nerve injury showed decreased density of expression of cavernous endothelial and smooth muscle makers than the sham operation group. The group with transplantation of HEN6 showed increased expression of cavernous endothelial and smooth muscle makers than the cavernous nerve injury group. Blue = DAPI, Green = SMA, Red = vWF. Sham = sham operation, CNI = cavernous nerve injury without stem cells transplantation. DAPI = 4’,6-diamidino-2-phenylindole, SMA = smooth muscle actin, vWF = von Willebrand factor, HEN6 = human telomerase reverse transcriptase immortalized cerebral endothelial progenitor cells

Back to article page

Basic and Clinical Andrology

ISSN: 2051-4190